Hive Blockchain
HIVE
Coinbase
COIN
Mawson Infrastructure
MIGI
The9 Ltd
NCTY
MicroStrategy
MSTR
US Stock MarketDetailed Quotes
ASND Ascendis Pharma A/S
- 134.430
- -2.860-2.08%
Close Jan 8 16:00 ET
- 134.430
- 0.0000.00%
Post 20:01 ET
8.04BMarket Cap-17.46P/E (TTM)
138.650High133.820Low500.34KVolume136.480Open137.290Pre Close67.85MTurnover0.84%Turnover RatioLossP/E (Static)59.81MShares161.00052wk High-80.07P/B7.98BFloat Cap111.09052wk Low--Dividend TTM59.37MShs Float183.980Historical High--Div YieldTTM3.52%Amplitude11.920Historical Low135.601Avg Price1Lot Size
About Ascendis Pharma A/S Company
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
Company Profile
SymbolASND
Company NameAscendis Pharma A/S
Listing DateJan 28, 2015
Issue Price18.00
Founded2006
CEOMr. Jan Moller Mikkelsen
MarketNASDAQ
Employees879
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressTuborg Boulevard 12
CityHellerup
ProvinceCapital Region
CountryDenmark
Zip Code2900
Phone45-70-22-22-44
Company Executives
- Name
- Position
- Salary
- Jan Moller Mikkelsen
- President, Chief Executive Officer and Director
- --
- Camilla Harder Hartvig
- Executive Vice President and Global Chief Commercial Officer
- --
- Lotte Sonderbjerg
- Executive Vice President and Chief Administrative Officer
- --
- Scott T Smith
- Executive Vice President and Chief Financial Officer
- --
- Michael Wolff Jensen
- Executive Vice President and Chief Legal Officer
- --
- Peter Rasmussen
- Vice President, Finance and Principal Accounting Officer
- --
- Dr. Kennett Sprogoe, PhD
- Executive Vice President and Head of Innovation and Research
- --
- Flemming Steen Jensen
- Executive Vice President, Product Supply and Quality
- --
- Dr. Stina Singel, M.D.
- Executive Vice President and Head of Clinical Development, Oncology
- --
- Dr. Albert Cha, M.D.,PhD
- Chairman of the Board
- --
- Siham Imani
- Independent Director
- --
- William Carl Fairey
- Independent Director
- --
- Lisa Bright
- Independent Director
- --
- Lars Holtug
- Independent Director
- --
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.